Information Journal Paper
APA:
Copy. (2019). ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, 38(1), 1-12. SID. https://sid.ir/paper/745198/en
Vancouver:
Copy. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH[Internet]. 2019;38(1):1-12. Available from: https://sid.ir/paper/745198/en
IEEE:
Copy, “ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway,” JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH, vol. 38, no. 1, pp. 1–12, 2019, [Online]. Available: https://sid.ir/paper/745198/en